Frederick Frank
Vice Chairman
Lehman Brothers

Frederick Frank is Vice Chairman and a Director of Lehman Brothers Inc. Before joining Lehman Brothers as a Partner in October, 1969, Mr. Frank was co-director of research, as well as Vice President and Director, of Smith, Barney & Co. Incorporated. He is a Chartered Financial Analyst, a member of The New York Society of Security Analysts and a past president of the Chemical Processing Industry Analysts.

Born in Salt Lake City on May 31, 1932, Mr. Frank graduated from the Hotchkiss School in 1950 and from Yale University in 1954. He then spent two years in the Army, most of the time stationed with Supreme Headquarters Allied Powers Europe (SHAPE) in Paris. After release from service, he attended Stanford Graduate School of Business Administration. He received his MBA from Stanford in 1958 and began his Wall Street career that year. He also has a CFA Degree.

In addition to serving the as the Chairman of the Board of Epix Pharmaceuticals, Mr. Frank is a Director of Landec Corporation; Institute for Systems Biology; and Pharmaceutical Product Development, Inc. He is Chairman of the National Genetics Foundation; a past director of the Salk Institute; a member of the Yale School of Organization and Management Advisory Board, a member of the Pharmaceutical Executive Magazine advisory board and The Journal of Life Sciences, Chairman of the Board of The Irvington Institute for Immunological Research, a member of the Advisory Board of The Harvard School of Public Health and also the John's Hopkin's Bloomberg School of Public Health, and he serves on the Advisory Board of the Massachusetts Institute of Technology Center for Biomedical Innovation. He is past President of the Board of the The Hotchkiss School and currently serves as a Director Emeritus.

Mr. Frank was honored for Outstanding Contributions in the Field of Immunology in 1998 by the Irvington Institute for Immunological Research, and, in 1997, he received the Biotech Meeting at Laguna Niguel Hall of Fame Award for Special Recognition for an Individual. He received The Albert Einstein Award from the Weizmann Institute of Science in 2004, the 2006 Gilda's Club of New York City Visionary Award and was selected The Top 100 Living Contributors to Biotechnology by Reed Elsevier and in 2007 he received the Award for Excellence from the American Liver Foundation.

Mr. Frank has provided investment banking services to an extensive number of companies in the pharmaceutical, biotechnology, healthcare service providers, medical device and nutraceutical industries, and has been involved in hundreds of financings and merger and acquisition transactions in the health care field.